Citigroup Inc Agenus Inc Transaction History

Citigroup Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.53 - $0.93 $8,721 - $15,303	16,455 Added 30.21%	70,924 $41,000
Q4 2023 Feb 09, 2024	SELL	$0.63 - $1.14 $411,228 - $744,128	-652,744 Reduced 92.3%	54,469 $45,000
Q3 2023 Nov 09, 2023	BUY	$1.12 - $1.88 $230,515 - $386,935	205,817 Added 41.05%	707,213 $799,000
Q2 2023 Aug 10, 2023	SELL	$1.31 - $2.04 $1.81 Million - $2.81 Million	-1,378,358 Reduced 73.33%	501,396 $802,000
Q1 2023 May 11, 2023	BUY	$1.45 - $2.95 $1.61 Million - $3.28 Million	1,111,207 Added 144.59%	1,879,754 $2.86 Million
Q4 2022 Feb 09, 2023	SELL	$2.02 - $3.25 $1.02 Million - $1.63 Million	-502,537 Reduced 39.54%	768,547 $1.84 Million
Q3 2022 Nov 10, 2022	BUY	$1.96 - $3.14 $512,438 - $820,946	261,448 Added 25.9%	1,271,084 $2.61 Million
Q2 2022 Aug 10, 2022	BUY	$1.3 - $2.64 $1.06 Million - $2.15 Million	813,478 Added 414.71%	1,009,636 $1.96 Million
Q1 2022 May 12, 2022	SELL	$2.35 - $3.47 $2.53 Million - $3.73 Million	-1,075,705 Reduced 84.58%	196,158 $482,000
Q4 2021 Feb 10, 2022	BUY	$2.92 - $5.74 $2.77 Million - $5.44 Million	948,163 Added 292.91%	1,271,863 $4.1 Million
Q3 2021 Nov 10, 2021	BUY	$4.98 - $6.63 $1.61 Million - $2.15 Million	323,700 New	323,700 $1.7 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.